A broad spectrum of process development and manufacturing technology services are available from Dowpharma for the production of recombinant proteins, peptides, and vaccines from microbial hosts. Dowpharma’s Pfēnex Expression TechnologyTM, a Pseudomonas-based technology is built around specially designed strains of Pseudomonas fluorescens. Services include molecular biology, high-expression vector development, analytical method development, process development and process scale up. Dowpharma has a range of vaccine production technologies for antigens and adjuvant proteins ranging from peptide epitopes and virus-like particles (VLPs) to bacterial toxins and heteromultimers. All systems, including high-yield Pfēnex Expression Technology, are designed for cost effectiveness, rapid supply and scalability.
Thermo Scientific represents Thermo Fisher Scientific’s broad range of high-end analytical instruments, chemistry and consumable supplies, laboratory equipment, software and services that enable integrated laboratory workflow solutions. Thermo Scientific is the new name for a trusted brand: HyClone.
HyClone, now sold as Thermo Scientific, offers researchers premium quality classical and serum-free media, sera and FBS replacements, reagents, buffers, WFI-quality water and single-use BioProcess Container Systems for handling large and small volumes of sterile liquids and powders.
BD Biosciences is a life sciences leader with more than 50 years of expertise in cell biology products and services. The Advanced Bioprocessing strategic platform developed products currently being used as critical components in the production of some of the most widely used drugs and vaccines on the global market today. BD Biosciences - Advanced Bioprocessing (BDB-AB) is playing a major role in biopharmaceutical drug production, enabling customers large and small to have a tremendous impact on the future of human healthcare. BDB-AB‘s novel portfolio of hydrolysates, cell culture media & supplements and services is the optimal choice for your mammalian cell culture and bacterial fermentation bioprocessing needs.
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of "turning science into solutions" on a daily basis.
Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs over 2,300 people, and in 2007 generated pro forma sales revenue of 375.9 million euros.
Merck is a global pharmaceutical and chemical company with sales of EUR 6.3 billion in 2006, a history that began in 1668, and a future shaped by 30,962 employees in 61 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Become a sponsor of this event, contact Sylvester Gabriel
|
